FedInvent™ Patent Applications

New Taxpayer Funded Applications for Thursday, April 06, 2023 

This page was updated on Thursday, April 06, 2023 at 05:27 AM GMT

FedInvent analyzed 150 taxpayer funded patent applications this week.

On Thursday, April 06, 2023, the United States Patent and Trademark Office (USPTO) published  150 patent applications; including 145 applications containing government interest statements and 29 applications where federal government agencies were an assignee or applicant on the patent application. Together, 150 patent applications published this week are the result of U.S. Government funded research & development.

Learn More About Taxpayer Funded Patents Here

The List of This Week's Patent Applications

Just a list — patent application publication number with a link and the title, for those patentistas who like to browse.

About The Icons On the List Below

  • The icon takes you to the full text version of the patent application at USPTO;
  • The icon takes you to the PDF version of the patent application at USPTO; and
  • The icon takes you to the details about the patent on the FedInvent Details page.
  • When you use the icon the patent you are interested appears at the top of the list on the details page.
Patent Application Title
001 20230103327
 
QUANTITATIVE CONTROL OF ACTIVITY OF ENGINEERED CELLS EXPRESSING SPYCATCHER AND SPYTAG UNIVERSAL IMMUNE RECEPTORS 
002 20230103330
 
MECHANISTIC BIOMARKER FOR PREDICTING THE SURVIVAL OF PANCREATIC CANCER PATIENTS 
003 20230103352
 
METHODS OF USE OF SOLUBLE CD24 FOR TREATING SARS-COV-2 INFECTION 
004 20230103362
 
EBNA1 Inhibitor Crystalline Forms, and Methods of Preparing and Using Same 
005 20230103407
 
MATERIALS AND METHODS FOR THE TREATMENT OF GAUCHER DISEASE 
006 20230103444
 
SMALL MOLECULE INHIBITORS OF ONCOGENIC CHD1L WITH PRECLINICAL ACTIVITY AGAINST COLORECTAL CANCER 
007 20230103452
 
SYSTEMS AND METHODS FOR 4D PRINTING FOR MEMBRANOUS TISSUE FABRICATION 
008 20230103498
 
ENPP1 Inhibitors and Their Use for the Treatment of Cancer 
009 20230103510
 
BIORESORBABLE RF COILS FOR POST-SURGICAL MONITORING BY MRI 
010 20230103554
 
TNFa SIGNALING TRIGGERS TUMOR-PROMOTING INFLAMMATION THAT CAN BE TARGETED TO THERAPY 
011 20230103556
 
SOLID ADHESIVE FILM FOR ACOUSTIC LINER AND METHOD 
012 20230103603
 
METHODS OF MITIGATING CATALYST DEACTIVATION 
013 20230103658
 
Resilient Reception Of Navigation Signals, Using Known Self-Coherence Features Of Those Signals 
014 20230103690
 
ENCAPSULATED FLEXIBLE ELECTRONICS FOR LONG-TERM IMPLANTATION 
015 20230103708
 
METHODS FOR TREATING EYE DISEASE 
016 20230103798
 
STABILIZED PROTEIN IONIC LIQUID APPLICATIONS 
017 20230103857
 
SEI PREFORMED GRAPHITE AND ASSOCIATED METHODS, APPARATUS, AND PRODUCTS 
018 20230103909
 
COMPOSITIONS AND METHODS FOR GENE EDITING 
019 20230103980
 
THERMAL STATE SWITCHES IN MACROPHAGES 
020 20230103984
 
Lyotropic Gyroid Mesophase Compositions, Polymer Compositions Comprising the Same, Methods of Preparation Thereof, and Methods of Using the Same 
021 20230104050
 
INDUCING PRODUCTION OF ANTI-OLIGOMANNOSE ANTIBODIES 
022 20230104136
 
Early Detection Of Hepatocellular Carcinoma 
023 20230104152
 
GRAPH-BASED METHOD FOR OPTIMAL ACTIVE ELECTRODE SELECTION IN COCHLEAR IMPLANTS AND APPLICATIONS OF SAME 
024 20230104170
 
PROBE FOR DETECTION OF CATHEPSIN ACTIVITY 
025 20230104171
 
Engineered Alum-binding SARS-CoV-2 Immunogens 
026 20230104288
 
METHODS AND SYSTEMS FOR A DIGITAL TRUST ARCHITECTURE 
027 20230104317
 
Systems and Methods to Identify Genetic Silencers and Applications Thereof 
028 20230104322
 
METHODS FOR IDENTIFYING PATTERNS OF IFN INDUCED EXPRESSION AND USE IN DIAGNOSIS, MONITORING AND THERAPY 
029 20230104455
 
PROCESSING AND VISUALIZATION OF PREDICTED AIRCRAFT TRAJECTORIES AND ESTIMATED TIME OF ARRIVAL PERFORMANCE 
030 20230104480
 
MICELLES AND VESICLES FOR THE DELIVERY OF GLYCOPEPTIDES 
031 20230104557
 
METHOD FOR TUNING LITHOTRIPSY FREQUENCY TO TARGET SIZE 
032 20230104649
 
Off-Platform Cable Presentation Rig 
033 20230104671
 
METHODS AND COMPOSITIONS FOR TREATING CARDIOMYOPATHY AND HEART FAILURE 
034 20230104822
 
ROBOTIC END EFFECTORS FOR USE WITH ROBOTIC MANIPULATORS 
035 20230104995
 
SYSTEM AND METHOD FOR BIOLOGICAL AND HYBRID NEURAL NETWORKS COMMUNICATION 
036 20230104998
 
SINGLE-MOLECULE PROTEIN AND PEPTIDE SEQUENCING 
037 20230105008
 
METHODS AND COMPOSITIONS FOR IDENTIFYING CASTRATION RESISTANT NEUROENDOCRINE PROSTATE CANCER 
038 20230105074
 
Central Payload Manager for Unmanned Systems 
039 20230105167
 
METHODS FOR GENETIC IDENTIFICATION AND RELATEDNESS DETECTION 
040 20230105186
 
Nanoparticle Modification of Human Adipose-Derived Mesenchymal Stem Cells for Treating Brain Cancer and Other Neurological Diseases 
041 20230105213
 
ADVANCED AERO DIFFUSERS FOR TURBINE FRAMES AND OUTLET GUIDE VANES 
042 20230105233
 
COMPLEX STRUCTURES FROM STIMULI-RESPONSIVE PROTEINS 
043 20230105323
 
High Pressure Furnace and Methods of Use 
044 20230105344
 
STRUCTURAL OPTIMIZATION METHOD TO IMPROVE THE THERANOSTIC PERFORMANCE OF PEPTIDE RECEPTOR-TARGETED RADIONUCLIDE THERAPY FOR CANCERS 
045 20230105381
 
COMPOSITIONS AND METHODS FOR BIOORTHOGONAL SURFACE COATING 
046 20230105479
 
OPTICALLY CONTROLLABLE FGFR STIMULATION USING WIRELESS CONTROLLED CELLULAR LIGHTING SYSTEM 
047 20230105484
 
COMPOUNDS FOR THE TREATMENT OF ACUTE ORGAN INJURY 
048 20230105528
 
CARGO TRANSPORT SYSTEM 
049 20230105578
 
VARIABLE POSITIVE DISPLACEMENT PUMP ACTUATOR SYSTEMS 
050 20230105609
 
Quality Assurance for Unattended Computer Vision Counting 
051 20230105656
 
Manipulating the Optical Phase of a Laser Beam 
052 20230105757
 
COMPOSITIONS AND METHODS OF TREATING CANCER 
053 20230105776
 
Topoisomerase II-alpha Inhibitors and Methods of Treating Cancer Using the Same 
054 20230105847
 
METHOD AND SYSTEM TO DETERMINE A MASK LEAKAGE RATE 
055 20230105867
 
Data Processing System to Detect Neurodevelopmental-Specific Learning Disorders 
056 20230105874
 
WEAKLY COUPLED ABSORBER TO PLASMONIC DEVICE 
057 20230105880
 
TAG THAT ENHANCES VEHICLE RADAR VISIBILITY OF OBJECTS 
058 20230105900
 
TECHNIQUE TO IMPROVE DEEP BRAIN STIMULATION TARGETING DURING INTRAOPERATIVE MICROELECTRODE RECORDINGS 
059 20230105993
 
RAPID POLYMERIZED CATECHOL BASED SURFACTANT ASSISTED INFILTRATION OF SOLID OXIDE ELECTROCHEMICAL CELL INFILTRATION USING SPRAYING METHOD 
060 20230105995
 
MULTIPLEXED LATERAL FLOW ASSAY FOR DETECTION OF HPV ASSOCIATED CANCER 
061 20230106030
 
OPTICAL PASS-THROUGH LINK TRAINING 
062 20230106114
 
INDUCIBLE CRISPR SYSTEM EXPRESSION AND APPLICATIONS THEREOF 
063 20230106124
 
BALLISTIC PENDULUM STABILIZER 
064 20230106126
 
CARGO TRANSPORT SYSTEM 
065 20230106131
 
POLYPEPTIDE CONJUGATES FOR INTRACELLULAR DELIVERY OF STAPLED PEPTIDES 
066 20230106158
 
DISSEMINATED NEOPLASIA CELLS AND METHODS OF THEIR USE TO CONTROL INVASIVE OR PEST SPECIES 
067 20230106189
 
PATTERNING OF DIODE/SUBSTRATE INTERFACE TO REDUCE THERMAL LENSING 
068 20230106294
 
DURABLE PHOTOPOLYMERIZABLE CROSS-LINKED ANTI-FOULING COATINGS 
069 20230106300
 
GaN VERTICAL-CHANNEL JUNCTION FIELD-EFFECT TRANSISTORS WITH REGROWN p-GaN BY METAL ORGANIC CHEMICAL VAPOR DEPOSITION (MOCVD) 
070 20230106379
 
NUCLEAR REACTOR FLOW CONTROL DEVICES AND ASSOCIATED REACTORS, COMPONENTS, AND METHODS 
071 20230106382
 
FILTERS WITH REDUCED ANGLE-OF-INCIDENCE DEPENDENCE 
072 20230106465
 
7-Gene Prognostic and Predictive Assay for Non-Small Cell Lung Cancer in Formalin Fixed and Paraffin Embedded Samples 
073 20230106574
 
TAILORING OF PORES IN AEROGELS USING 3D PRINTED STRUCTURES 
074 20230106721
 
Protection of Next-Generation Probiotics during Processing 
075 20230106738
 
COMPOSITIONS, METHODS, AND KITS FOR DETECTING THE NUMBER AND GENOMIC LOCATIONS OF POLYMORPHIC LINE-1 ELEMENTS IN AN INDIVIDUAL 
076 20230106760
 
ANTIBACTERIAL AND ANTIFUNGAL POLYKETIDES FROM ENVIRONMENTAL AMYCOLATOPSIS SPP 
077 20230106783
 
High Power Flux Cancelling Current Steering Inductor Without A Gap 
078 20230106799
 
THERMOTACTILE STIMULATION PROSTHESIS 
079 20230106815
 
INFRARED TRANSPARENT FOAM COMPOSITE FOR DEEP SUBAMBIENT COOLING OF VIRTUALLY ANY SURFACE 
080 20230106858
 
COMPOUNDS, INCLUDING NONSYMMETRICAL POLYAROMATIC HYDROCARBONS, AND METHODS 
081 20230106973
 
METHODS FOR EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES AND USE THEREOF 
082 20230107007
 
SYSTEMS AND METHODS FOR HYBRID-MODE-FAMILY OPTICAL PARAMETRIC OSCILLATION FOR ROBUST COHERENT LIGHT GENERATION ON-CHIP 
083 20230107032
 
BENZODIAZEPINE DERIVATIVES, COMPOSITIONS, AND METHODS FOR TREATING COGNITIVE IMPAIRMENT 
084 20230107049
 
ANALYSIS OF MICROBIOME FOR DIAGNOSIS AND TREATING OF URINARY STONE DISEASE 
085 20230107068
 
ANTENNA STEERING-INDUCED PHASE CENTER ERROR LIMITER 
086 20230107105
 
MANAGING HAZARDS IN A MEMORY CONTROLLER 
087 20230107113
 
NASAL DEVICE AND ASSOCIATED METHOD OF MEASURING AN ASPECT OF GAS FLOWING THROUGH A USER\'S NOSE 
088 20230107117
 
CONDITIONAL-siRNAS AND USES THEREOF IN TREATING CARDIAC HYPERTROPHY 
089 20230107163
 
Systems and Methods for Gas-Liquid Contactors for Rapid Carbon Capture 
090 20230107230
 
FLUORINE SUBSTITUTED CYCLOHEXENE ANALOGUES OF GAMMA- AMINOBUTYRIC ACID (GABA) 
091 20230107235
 
NOTCH3 Agonist Compositions and Methods for Treating Small Vessel Diseases 
092 20230107239
 
Mechanochemical Based Synthesis of Perfluoropyridine Monomers for Polymerization 
093 20230107256
 
QUINOLINE DERIVED SMALL MOLECULE INHIBITORS OF NICOTINAMIDE N-METHYLTRANSFERASE (NNMT) AND USES THEREOF 
094 20230107327
 
SYNERGISTIC ADDITIVES FOR HIGH VOLUME LITHIUM ION BATTERIES 
095 20230107377
 
SYNTHETIC LUNG SURFACTANT WITH ENHANCED STABILITY AND EFFECTIVENESS 
096 20230107506
 
COHERENT HIGH SPEED OPTICAL VALVE 
097 20230107620
 
SYSTEMS AND METHODS FOR OPTIMIZED PATIENT SPECIFIC TISSUE ENGINEERING VASCULAR GRAFTS 
098 20230107644
 
MONOCLONAL ANTIBODIES AGAINST THE HEMAGGLUTININ (HA) AND NEURAMINIDASE (NA) OF INFLUENZA H3N2 VIRUSES 
099 20230107647
 
SINGLE MOLECULE PEPTIDE SEQUENCING 
100 20230107668
 
STOICHIOMETRIC RECOVERY OF UF4 FROM UF6 DISSOLVED IN IONIC LIQUIDS 
101 20230107700
 
SYSTEMS AND METHODS FOR DISTRIBUTION ITEM PROCESSING 
102 20230107757
 
POLY(BETA-AMINO ESTER)-CO-POLYETHYLENE GLYCOL (PEG-PBAE-PEG) POLYMERS FOR GENE AND DRUG DELIVERY 
103 20230107770
 
METHOD OF ENHANCING IMMUNOTHERAPY USING ER STRESS PATHWAY INHIBITORS 
104 20230107804
 
Dendritic Cell Generator 
105 20230107986
 
METHODS AND SYSTEMS FOR METHYLOTROPHIC PRODUCTION OF ORGANIC COMPOUNDS 
106 20230108025
 
KIR 7.1 GENE THERAPY VECTORS AND METHODS OF USING THE SAME 
107 20230108071
 
SYSTEMS AND METHODS FOR SELF-TRACKING REAL-TIME HIGH RESOLUTION WIDE-FIELD OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY 
108 20230108123
 
COMPOSITIONS AND METHODS FOR TREATING A NEURODEGENERATIVE OR DEVELOPMENTAL DISORDER 
109 20230108142
 
ROBOTIC BRACE AND METHODS OF MANUFACTURE THEREOF 
110 20230108258
 
ANTIBODY-FREE RAPID DETECTION OF SARS-COV-2 PROTEINS USING CORONA PHASE MOLECULAR RECOGNITION (COPHMORE) 
111 20230108270
 
STABILIZATION OF COMPOUNDS AS CYCLODEXTRIN COMPLEXES 
112 20230108300
 
COMPOSITIONS AND METHODS OF T CELL RECEPTOR VB FAMILY MEMBER TARGETING FOR THE TREATMENT OF T CELL ASSOCIATED DISEASE 
113 20230108316
 
METHODS FOR REHABILITATING HEART FAILURE USING GENE THERAPY 
114 20230108342
 
COMPOSITE PRESSURE VESSEL ASSEMBLY AND METHOD OF MANUFACTURING 
115 20230108353
 
SYNERGISTIC ADDITIVES FOR HIGH VOLUME LITHIUM ION BATTERIES 
116 20230108381
 
FERRATE COMPOSITIONS FOR SURFACE DISINFECTION 
117 20230108385
 
EDIBLE PLANT-DERIVED MICROVESICLE COMPOSITIONS FOR DELIVERY OF miRNA AND METHODS FOR TREATMENT OF CANCER 
118 20230108395
 
FAST RESPONSE ROTOR SYSTEM 
119 20230108479
 
Substituted N-Benzhydrylacetamide Inhibitors of Jamanji Domain Histone Demethylases for the Treatment of Cancer 
120 20230108485
 
MONOCOQUE SHELL AND TUBE HEAT EXCHANGER 
121 20230108494
 
ACTIVITY-BASED PROBES WITH UNNATURAL AMINO ACIDS TO MONITOR PROTEASOME ACTIVITY 
122 20230108512
 
PRESSURE EQUILIBRATED THERMAL INSULATION GAP 
123 20230108561
 
IN-OPERANDO ELECTROCHEMICAL DENDRITE HEALING IN LITHIUM-ION BATTERY CELLS 
124 20230108618
 
INTEGRATED ELECTRO-MAGNETICALLY PRELOADED KINEMATIC JOINT FOR ON-ORBIT ASSEMBLY OF MODULAR SPACE VEHICLES 
125 20230108651
 
ANALOG SWITCHED-CAPACITOR NEURAL NETWORK 
126 20230108715
 
METHOD AND SYSTEM FOR THE NON-INVASIVE RECORDING OF MARINE MAMMAL SLEEP IN THE WILD 
127 20230108718
 
LOW-COBALT AND COBALT-FREE, HIGH-ENERGY CATHODE MATERIALS FOR LITHIUM BATTERIES 
128 20230108742
 
NANOSTRUCTURED INSULATION FOR ELECTRIC MACHINES 
129 20230108784
 
NOVEL CRISPR ENZYMES AND SYSTEMS 
130 20230108813
 
CATHODE MATERIALS FOR USE IN LITHIUM CELLS AND BATTERIES 
131 20230108944
 
SIMULATION SYSTEM FOR TESTING A RADAR SYSTEM 
132 20230108947
 
POLYMER EXCIPIENTS FOR BIOPHARMACEUTICAL FORMULATIONS 
133 20230109020
 
Nucleic Acid and Other Compositions and Methods for the Modulation of Cell Membranes 
134 20230109065
 
METHODS FOR DIAGNOSIS AND PREDICTION OF GENETIC DISEASES AND PHENOTYPES FROM LGD MUTATIONS 
135 20230109070
 
CLINICAL- AND INDUSTRIAL-SCALE INTACT-TISSUE SEQUENCING 
136 20230109146
 
METHODS FOR PRODUCING RADIONUCLIDES USING MINIMAL TARGETING MATERIAL 
137 20230109152
 
ULTRASONIC GENETICALLY ENCODED CALCIUM INDICATORS 
138 20230109193
 
Synergistic Combination of Alum and Non-Liposome, Non-Micelle Particle Vaccine Adjuvants 
139 20230109259
 
STABILIZED PROTEIN IONIC LIQUID APPLICATIONS 
140 20230109266
 
DELIVERY DROP POINTS FOR AUTONOMOUS DELIVERY VEHICLES 
141 20230109355
 
ULTRA-SENSITIVE COMPLAINT STRAIN SENSORS 
142 20230109371
 
SELF-HEALING POLYMER-MODIFIED CEMENTS FOR AMBIENT TEMPERATURE APPLICATIONS 
143 20230109376
 
BIOENERGETICALLY ACTIVE ESTERS FOR HEALTH AND DISEASE 
144 20230109434
 
CELL-FREE BIOSENSORS TO DETECT CREATININE, CREATINE, AND SARCOSINE 
145 20230109441
 
Scale Up Manufacturing of Waste Coal Combustion Ash-Based Lightweight Aggregate 
146 20230109450
 
PLASTIC WASTE CONVERSION TO LUBRICANT PRODUCTION 
147 20230109455
 
SELECTIVE REAL-TIME GAS SENSING 
148 20230109457
 
USE OF CDK9 INHIBITORS TO REDUCE CARTILAGE DEGRADATION 
149 20230109468
 
Fabrication-Free Microfluidic Device for Scalable, High-Volume Bacterial Electroporation 
150 20230109667
 
PCR-Activated Sorting (PAS) 

Up to Start Of Table

Patent Applications Count By Department

The count of taxpayer-funded patents granted by the United States Patent and Trademark Office (USPTO) this week that contain a Government Interest Statement in the body of the patent documents or where the government is an assignee. Agency numbers are aggregated by the agency named in the Government Interests Statement and the contract number cited in the patent.

Department This Week This Year
Department of Health and Human Services (HHS) 77 940
Department of Defense (DOD) 34 504
Department of Energy (DOE) 26 330
National Science Foundation (NSF) 15 287
United States Postal Service (USPS) 3 19
Department of Homeland Security (DHS) 2 14
Department of Transportation (USDOT) 2 6
Department of Veterans Affairs (DVA) 2 27
Small Business Administration (SBA) 2 28
Department of Commerce (DOC) 1 17
Department of Education (ED) 1 1
Department of Justice (DOJ) 1 2
Department of the Interior (DOI) 1 6
National Aeronautics and Space Administration (NASA) 1 39
National Geospatial Intelligence Agency (NGA) 1 2
National Security Agency (NSA) 1 4
Government Rights Acknowledged 3 35

Patent Applications by Funding Agency

FedInvent Patents reflects patents with Government Interests Statements in the body of the patent as required by the Bayh-Dole Act indicating the holder of a federal contract, grant, or cooperative agreement has elected to retain the title of inventions conceived and reduced to practice during that contract; and patents where an agency of the US Federal government has elected to retain the title to the patent.

About The Icons On the List Below

  • The icon takes you to the full text version of the patent application at USPTO;
  • The icon takes you to the PDF version of the patent application at USPTO; and
  • The icon takes you to the details about the patent on the FedInvent Details page.
  • When you use the icon the patent you are interested appears at the top of the list on the details page.

Click the Panel to See The Patent Application for Each Agency

Take Me To The Details
Patent Title
001 20230103327
 
QUANTITATIVE CONTROL OF ACTIVITY OF ENGINEERED CELLS EXPRESSING SPYCATCHER AND SPYTAG UNIVERSAL IMMUNE RECEPTORS 
002 20230103330
 
MECHANISTIC BIOMARKER FOR PREDICTING THE SURVIVAL OF PANCREATIC CANCER PATIENTS 
003 20230103352
 
METHODS OF USE OF SOLUBLE CD24 FOR TREATING SARS-COV-2 INFECTION 
004 20230103362
 
EBNA1 Inhibitor Crystalline Forms, and Methods of Preparing and Using Same 
005 20230103407
 
MATERIALS AND METHODS FOR THE TREATMENT OF GAUCHER DISEASE 
006 20230103452
 
SYSTEMS AND METHODS FOR 4D PRINTING FOR MEMBRANOUS TISSUE FABRICATION 
007 20230103498
 
ENPP1 Inhibitors and Their Use for the Treatment of Cancer 
008 20230103510
 
BIORESORBABLE RF COILS FOR POST-SURGICAL MONITORING BY MRI 
009 20230103554
 
TNFa SIGNALING TRIGGERS TUMOR-PROMOTING INFLAMMATION THAT CAN BE TARGETED TO THERAPY 
010 20230103708
 
METHODS FOR TREATING EYE DISEASE 
011 20230103909
 
COMPOSITIONS AND METHODS FOR GENE EDITING 
012 20230103980
 
THERMAL STATE SWITCHES IN MACROPHAGES 
013 20230104050
 
INDUCING PRODUCTION OF ANTI-OLIGOMANNOSE ANTIBODIES 
014 20230104136
 
Early Detection Of Hepatocellular Carcinoma 
015 20230104152
 
GRAPH-BASED METHOD FOR OPTIMAL ACTIVE ELECTRODE SELECTION IN COCHLEAR IMPLANTS AND APPLICATIONS OF SAME 
016 20230104170
 
PROBE FOR DETECTION OF CATHEPSIN ACTIVITY 
017 20230104171
 
Engineered Alum-binding SARS-CoV-2 Immunogens 
018 20230104317
 
Systems and Methods to Identify Genetic Silencers and Applications Thereof 
019 20230104322
 
METHODS FOR IDENTIFYING PATTERNS OF IFN INDUCED EXPRESSION AND USE IN DIAGNOSIS, MONITORING AND THERAPY 
020 20230104480
 
MICELLES AND VESICLES FOR THE DELIVERY OF GLYCOPEPTIDES 
021 20230104557
 
METHOD FOR TUNING LITHOTRIPSY FREQUENCY TO TARGET SIZE 
022 20230104671
 
METHODS AND COMPOSITIONS FOR TREATING CARDIOMYOPATHY AND HEART FAILURE 
023 20230104995
 
SYSTEM AND METHOD FOR BIOLOGICAL AND HYBRID NEURAL NETWORKS COMMUNICATION 
024 20230104998
 
SINGLE-MOLECULE PROTEIN AND PEPTIDE SEQUENCING 
025 20230105008
 
METHODS AND COMPOSITIONS FOR IDENTIFYING CASTRATION RESISTANT NEUROENDOCRINE PROSTATE CANCER 
026 20230105186
 
Nanoparticle Modification of Human Adipose-Derived Mesenchymal Stem Cells for Treating Brain Cancer and Other Neurological Diseases 
027 20230105233
 
COMPLEX STRUCTURES FROM STIMULI-RESPONSIVE PROTEINS 
028 20230105344
 
STRUCTURAL OPTIMIZATION METHOD TO IMPROVE THE THERANOSTIC PERFORMANCE OF PEPTIDE RECEPTOR-TARGETED RADIONUCLIDE THERAPY FOR CANCERS 
029 20230105381
 
COMPOSITIONS AND METHODS FOR BIOORTHOGONAL SURFACE COATING 
030 20230105479
 
OPTICALLY CONTROLLABLE FGFR STIMULATION USING WIRELESS CONTROLLED CELLULAR LIGHTING SYSTEM 
031 20230105484
 
COMPOUNDS FOR THE TREATMENT OF ACUTE ORGAN INJURY 
032 20230105757
 
COMPOSITIONS AND METHODS OF TREATING CANCER 
033 20230105847
 
METHOD AND SYSTEM TO DETERMINE A MASK LEAKAGE RATE 
034 20230105900
 
TECHNIQUE TO IMPROVE DEEP BRAIN STIMULATION TARGETING DURING INTRAOPERATIVE MICROELECTRODE RECORDINGS 
035 20230105995
 
MULTIPLEXED LATERAL FLOW ASSAY FOR DETECTION OF HPV ASSOCIATED CANCER 
036 20230106131
 
POLYPEPTIDE CONJUGATES FOR INTRACELLULAR DELIVERY OF STAPLED PEPTIDES 
037 20230106294
 
DURABLE PHOTOPOLYMERIZABLE CROSS-LINKED ANTI-FOULING COATINGS 
038 20230106465
 
7-Gene Prognostic and Predictive Assay for Non-Small Cell Lung Cancer in Formalin Fixed and Paraffin Embedded Samples 
039 20230106738
 
COMPOSITIONS, METHODS, AND KITS FOR DETECTING THE NUMBER AND GENOMIC LOCATIONS OF POLYMORPHIC LINE-1 ELEMENTS IN AN INDIVIDUAL 
040 20230106760
 
ANTIBACTERIAL AND ANTIFUNGAL POLYKETIDES FROM ENVIRONMENTAL AMYCOLATOPSIS SPP 
041 20230106973
 
METHODS FOR EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES AND USE THEREOF 
042 20230107032
 
BENZODIAZEPINE DERIVATIVES, COMPOSITIONS, AND METHODS FOR TREATING COGNITIVE IMPAIRMENT 
043 20230107049
 
ANALYSIS OF MICROBIOME FOR DIAGNOSIS AND TREATING OF URINARY STONE DISEASE 
044 20230107117
 
CONDITIONAL-siRNAS AND USES THEREOF IN TREATING CARDIAC HYPERTROPHY 
045 20230107230
 
FLUORINE SUBSTITUTED CYCLOHEXENE ANALOGUES OF GAMMA- AMINOBUTYRIC ACID (GABA) 
046 20230107235
 
NOTCH3 Agonist Compositions and Methods for Treating Small Vessel Diseases 
047 20230107377
 
SYNTHETIC LUNG SURFACTANT WITH ENHANCED STABILITY AND EFFECTIVENESS 
048 20230107620
 
SYSTEMS AND METHODS FOR OPTIMIZED PATIENT SPECIFIC TISSUE ENGINEERING VASCULAR GRAFTS 
049 20230107644
 
MONOCLONAL ANTIBODIES AGAINST THE HEMAGGLUTININ (HA) AND NEURAMINIDASE (NA) OF INFLUENZA H3N2 VIRUSES 
050 20230107647
 
SINGLE MOLECULE PEPTIDE SEQUENCING 
051 20230107757
 
POLY(BETA-AMINO ESTER)-CO-POLYETHYLENE GLYCOL (PEG-PBAE-PEG) POLYMERS FOR GENE AND DRUG DELIVERY 
052 20230107770
 
METHOD OF ENHANCING IMMUNOTHERAPY USING ER STRESS PATHWAY INHIBITORS 
053 20230107804
 
Dendritic Cell Generator 
054 20230108025
 
KIR 7.1 GENE THERAPY VECTORS AND METHODS OF USING THE SAME 
055 20230108071
 
SYSTEMS AND METHODS FOR SELF-TRACKING REAL-TIME HIGH RESOLUTION WIDE-FIELD OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY 
056 20230108123
 
COMPOSITIONS AND METHODS FOR TREATING A NEURODEGENERATIVE OR DEVELOPMENTAL DISORDER 
057 20230108258
 
ANTIBODY-FREE RAPID DETECTION OF SARS-COV-2 PROTEINS USING CORONA PHASE MOLECULAR RECOGNITION (COPHMORE) 
058 20230108270
 
STABILIZATION OF COMPOUNDS AS CYCLODEXTRIN COMPLEXES 
059 20230108300
 
COMPOSITIONS AND METHODS OF T CELL RECEPTOR VB FAMILY MEMBER TARGETING FOR THE TREATMENT OF T CELL ASSOCIATED DISEASE 
060 20230108316
 
METHODS FOR REHABILITATING HEART FAILURE USING GENE THERAPY 
061 20230108385
 
EDIBLE PLANT-DERIVED MICROVESICLE COMPOSITIONS FOR DELIVERY OF miRNA AND METHODS FOR TREATMENT OF CANCER 
062 20230108479
 
Substituted N-Benzhydrylacetamide Inhibitors of Jamanji Domain Histone Demethylases for the Treatment of Cancer 
063 20230108494
 
ACTIVITY-BASED PROBES WITH UNNATURAL AMINO ACIDS TO MONITOR PROTEASOME ACTIVITY 
064 20230108784
 
NOVEL CRISPR ENZYMES AND SYSTEMS 
065 20230108947
 
POLYMER EXCIPIENTS FOR BIOPHARMACEUTICAL FORMULATIONS 
066 20230109020
 
Nucleic Acid and Other Compositions and Methods for the Modulation of Cell Membranes 
067 20230109065
 
METHODS FOR DIAGNOSIS AND PREDICTION OF GENETIC DISEASES AND PHENOTYPES FROM LGD MUTATIONS 
068 20230109070
 
CLINICAL- AND INDUSTRIAL-SCALE INTACT-TISSUE SEQUENCING 
069 20230109146
 
METHODS FOR PRODUCING RADIONUCLIDES USING MINIMAL TARGETING MATERIAL 
070 20230109152
 
ULTRASONIC GENETICALLY ENCODED CALCIUM INDICATORS 
071 20230109193
 
Synergistic Combination of Alum and Non-Liposome, Non-Micelle Particle Vaccine Adjuvants 
072 20230109376
 
BIOENERGETICALLY ACTIVE ESTERS FOR HEALTH AND DISEASE 
073 20230109434
 
CELL-FREE BIOSENSORS TO DETECT CREATININE, CREATINE, AND SARCOSINE 
074 20230109455
 
SELECTIVE REAL-TIME GAS SENSING 
075 20230109457
 
USE OF CDK9 INHIBITORS TO REDUCE CARTILAGE DEGRADATION 
076 20230109468
 
Fabrication-Free Microfluidic Device for Scalable, High-Volume Bacterial Electroporation 
077 20230109667
 
PCR-Activated Sorting (PAS) 

Up to Start Of Table

Take Me To The Details

Department of Defense (DOD) Agencies

Patent Title
001 20230103444
 
SMALL MOLECULE INHIBITORS OF ONCOGENIC CHD1L WITH PRECLINICAL ACTIVITY AGAINST COLORECTAL CANCER 
002 20230103498
 
ENPP1 Inhibitors and Their Use for the Treatment of Cancer 
003 20230103690
 
ENCAPSULATED FLEXIBLE ELECTRONICS FOR LONG-TERM IMPLANTATION 
004 20230103909
 
COMPOSITIONS AND METHODS FOR GENE EDITING 
005 20230103984
 
Lyotropic Gyroid Mesophase Compositions, Polymer Compositions Comprising the Same, Methods of Preparation Thereof, and Methods of Using the Same 
006 20230105776
 
Topoisomerase II-alpha Inhibitors and Methods of Treating Cancer Using the Same 
007 20230106114
 
INDUCIBLE CRISPR SYSTEM EXPRESSION AND APPLICATIONS THEREOF 
008 20230107007
 
SYSTEMS AND METHODS FOR HYBRID-MODE-FAMILY OPTICAL PARAMETRIC OSCILLATION FOR ROBUST COHERENT LIGHT GENERATION ON-CHIP 
009 20230107105
 
MANAGING HAZARDS IN A MEMORY CONTROLLER 
010 20230107256
 
QUINOLINE DERIVED SMALL MOLECULE INHIBITORS OF NICOTINAMIDE N-METHYLTRANSFERASE (NNMT) AND USES THEREOF 

Department of the ARMY (DOA)

Patent Title
001 20230103444
 
SMALL MOLECULE INHIBITORS OF ONCOGENIC CHD1L WITH PRECLINICAL ACTIVITY AGAINST COLORECTAL CANCER 
002 20230103498
 
ENPP1 Inhibitors and Their Use for the Treatment of Cancer 
003 20230104050
 
INDUCING PRODUCTION OF ANTI-OLIGOMANNOSE ANTIBODIES 
004 20230104171
 
Engineered Alum-binding SARS-CoV-2 Immunogens 
005 20230105776
 
Topoisomerase II-alpha Inhibitors and Methods of Treating Cancer Using the Same 
006 20230106114
 
INDUCIBLE CRISPR SYSTEM EXPRESSION AND APPLICATIONS THEREOF 
007 20230107256
 
QUINOLINE DERIVED SMALL MOLECULE INHIBITORS OF NICOTINAMIDE N-METHYLTRANSFERASE (NNMT) AND USES THEREOF 
008 20230107506
 
COHERENT HIGH SPEED OPTICAL VALVE 
009 20230108395
 
FAST RESPONSE ROTOR SYSTEM 
010 20230109070
 
CLINICAL- AND INDUSTRIAL-SCALE INTACT-TISSUE SEQUENCING 
011 20230109355
 
ULTRA-SENSITIVE COMPLAINT STRAIN SENSORS 

Department of the Navy (DON) | United States Marine Corps (USMC)

Patent Title
001 20230105074
 
Central Payload Manager for Unmanned Systems 
002 20230105528
 
CARGO TRANSPORT SYSTEM 
003 20230105874
 
WEAKLY COUPLED ABSORBER TO PLASMONIC DEVICE 
004 20230106126
 
CARGO TRANSPORT SYSTEM 
005 20230107647
 
SINGLE MOLECULE PEPTIDE SEQUENCING 
006 20230108485
 
MONOCOQUE SHELL AND TUBE HEAT EXCHANGER 
007 20230108715
 
METHOD AND SYSTEM FOR THE NON-INVASIVE RECORDING OF MARINE MAMMAL SLEEP IN THE WILD 
008 20230108742
 
NANOSTRUCTURED INSULATION FOR ELECTRIC MACHINES 

Department of the Air Force (DAF)| United States Space Force (USSF)

Patent Title
001 20230103798
 
STABILIZED PROTEIN IONIC LIQUID APPLICATIONS 
002 20230104649
 
Off-Platform Cable Presentation Rig 
003 20230105578
 
VARIABLE POSITIVE DISPLACEMENT PUMP ACTUATOR SYSTEMS 
004 20230105656
 
Manipulating the Optical Phase of a Laser Beam 
005 20230106783
 
High Power Flux Cancelling Current Steering Inductor Without A Gap 
006 20230107239
 
Mechanochemical Based Synthesis of Perfluoropyridine Monomers for Polymerization 
007 20230108618
 
INTEGRATED ELECTRO-MAGNETICALLY PRELOADED KINEMATIC JOINT FOR ON-ORBIT ASSEMBLY OF MODULAR SPACE VEHICLES 
008 20230108651
 
ANALOG SWITCHED-CAPACITOR NEURAL NETWORK 
009 20230109259
 
STABILIZED PROTEIN IONIC LIQUID APPLICATIONS 

Up to Start Of Table

Take Me To The Details
Patent Title
001 20230103603
 
METHODS OF MITIGATING CATALYST DEACTIVATION 
002 20230103857
 
SEI PREFORMED GRAPHITE AND ASSOCIATED METHODS, APPARATUS, AND PRODUCTS 
003 20230105323
 
High Pressure Furnace and Methods of Use 
004 20230105880
 
TAG THAT ENHANCES VEHICLE RADAR VISIBILITY OF OBJECTS 
005 20230105993
 
RAPID POLYMERIZED CATECHOL BASED SURFACTANT ASSISTED INFILTRATION OF SOLID OXIDE ELECTROCHEMICAL CELL INFILTRATION USING SPRAYING METHOD 
006 20230106189
 
PATTERNING OF DIODE/SUBSTRATE INTERFACE TO REDUCE THERMAL LENSING 
007 20230106300
 
GaN VERTICAL-CHANNEL JUNCTION FIELD-EFFECT TRANSISTORS WITH REGROWN p-GaN BY METAL ORGANIC CHEMICAL VAPOR DEPOSITION (MOCVD) 
008 20230106379
 
NUCLEAR REACTOR FLOW CONTROL DEVICES AND ASSOCIATED REACTORS, COMPONENTS, AND METHODS 
009 20230106574
 
TAILORING OF PORES IN AEROGELS USING 3D PRINTED STRUCTURES 
010 20230106815
 
INFRARED TRANSPARENT FOAM COMPOSITE FOR DEEP SUBAMBIENT COOLING OF VIRTUALLY ANY SURFACE 
011 20230107113
 
NASAL DEVICE AND ASSOCIATED METHOD OF MEASURING AN ASPECT OF GAS FLOWING THROUGH A USER\'S NOSE 
012 20230107163
 
Systems and Methods for Gas-Liquid Contactors for Rapid Carbon Capture 
013 20230107327
 
SYNERGISTIC ADDITIVES FOR HIGH VOLUME LITHIUM ION BATTERIES 
014 20230107668
 
STOICHIOMETRIC RECOVERY OF UF4 FROM UF6 DISSOLVED IN IONIC LIQUIDS 
015 20230107986
 
METHODS AND SYSTEMS FOR METHYLOTROPHIC PRODUCTION OF ORGANIC COMPOUNDS 
016 20230108342
 
COMPOSITE PRESSURE VESSEL ASSEMBLY AND METHOD OF MANUFACTURING 
017 20230108353
 
SYNERGISTIC ADDITIVES FOR HIGH VOLUME LITHIUM ION BATTERIES 
018 20230108485
 
MONOCOQUE SHELL AND TUBE HEAT EXCHANGER 
019 20230108512
 
PRESSURE EQUILIBRATED THERMAL INSULATION GAP 
020 20230108561
 
IN-OPERANDO ELECTROCHEMICAL DENDRITE HEALING IN LITHIUM-ION BATTERY CELLS 
021 20230108718
 
LOW-COBALT AND COBALT-FREE, HIGH-ENERGY CATHODE MATERIALS FOR LITHIUM BATTERIES 
022 20230108813
 
CATHODE MATERIALS FOR USE IN LITHIUM CELLS AND BATTERIES 
023 20230108944
 
SIMULATION SYSTEM FOR TESTING A RADAR SYSTEM 
024 20230109146
 
METHODS FOR PRODUCING RADIONUCLIDES USING MINIMAL TARGETING MATERIAL 
025 20230109371
 
SELF-HEALING POLYMER-MODIFIED CEMENTS FOR AMBIENT TEMPERATURE APPLICATIONS 
026 20230109450
 
PLASTIC WASTE CONVERSION TO LUBRICANT PRODUCTION 

Up to Start Of Table

Emerging Technology

Emerging Climate Change Technologies

Patents containing 'Y" CPC symbols indicate emerging technologies important to US scientific leadership.

Patent documents that contain a Y02 or Y04 CPC symbol are already classified elsewhere. USPTO add the Y symbols to the classification data is to monitor new technological development covering clean technology and inventions impacting climate change, important American science and technology interests.

Y02 — Green House Gas Mitigation — Y02 covers selected technologies, which control, reduce or prevent anthropogenic emissions of greenhouse gases (GHG), in the framework of the Kyoto Protocol and the Paris Agreement, and technologies that allow adapting to the adverse effects of climate change. Y02A covers technologies for adaptation to climate change, — technologies that allow adapting to the adverse effects of climate change in human, industrial (including agriculture and livestock), and economic activities. Y02P covers climate change mitigation technologies in any kind of industrial processing or production activity, including the agroalimentary industry (relating to agriculture and food), agriculture, fishing, ranching, and the like.

Y04 — Enabling Technologies — Y04 is focused on the information and communications inventions that facilitate climate change technology. Y04S covers systems integrating technologies related to power network operation, communication or information technologies for improving electrical power generation, transmission, distribution, management, or usage. Examples of the art covered here are technologies related to smart grids, home appliances, and systems supporting the interoperability of electric or hybrid vehicles.

About The Icons On the List Below

  • The icon takes you to the full text version of the patent application at USPTO;
  • The icon takes you to the PDF version of the patent application at USPTO; and
  • The icon takes you to the details about the patent on the FedInvent Details page.
  • When you use the icon the patent application you are interested appears at the top of the list on the details page.
Class
Y02E Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
20230107986  METHODS AND SYSTEMS FOR METHYLOTROPHIC PRODUCTION OF ORGANIC COMPOUNDS      
20230108342  COMPOSITE PRESSURE VESSEL ASSEMBLY AND METHOD OF MANUFACTURING      

Count of patent applications funded by The Department of Health and Human Services (HHS).

Department | Agency This Week This Year
Department of Health and Human Services (HHS)77940
National Institutes of Health (NIH)76911
National Cancer Institute (NCI)17222
National Institute of Neurological Disorders and Stroke (NINDS)1284
National Institute of General Medical Sciences (NIGMS)10150
National Institute of Allergy and Infectious Diseases (NIAID)7127
National Institute of Biomedical Imaging and Bioengineering (NIBIB)668
National Institute of Mental Health (NIMH)531
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)567
National Human Genome Research Institute (NHGRI)527
National Heart, Lung, and Blood Institute (NHLBI)4114
National Eye Institute (NEI)423
National Institute of Environmental Health Sciences (NIEHS)310
National Institute on Drug Abuse (NIDA)316
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)326
National Institute on Aging (NIA)335
National Library of Medicine (NLM)24
National Institute of Dental and Craniofacial Research (NIDCR)212
National Institute on Deafness and Other Communication Disorders (NIDCD)212
National Center for Research Resources (NCRR)29
NIH Office of the Director (NIHOD)118
National Institute of Child Health and Human Development (NICHD)124
National Center for Advancing Translational Sciences (NCATS)120
Centers for Disease Control and Prevention (CDC)14
National Institute for Occupational Safety and Health (NIOSH)11

Up to Start Of Table

Higher Education Research and Development (HERD)

FedInvent follows the HERD the Higher Education Research and Development institutions — the colleges and universities; research institutions, and medical schools that benefit from federal funding and rely on it to make important discoveries that drive American innovation. Taxpayer funded patents coming from mostly American and sometime foreign universities are an important indicia of the vitality of the American innovation ecosphere.

MEMBERS OF THE HERD

The National Science Foundation (NSF) Higher Education Research and Development (HERD) Survey is the primary source of information on R&D expenditures at 916 US colleges and universities that expended at least $150,000 in separately accounted for R&D in the fiscal year. We use the NSF list to keep track of which colleges and universities are receiving taxpayer-funded patents and filing patent applications.

WATCH This SPACE

We're working on our data analytics and will be reporting taxpayer-funded patents and patent applications shortly. In the meantime, FedInvent will post interesting information about the HERD Innovation Ecosphere here.

Top Ten Universities By R&D Expenditures
  1. Johns Hopkins University
  2. University of Michigan
  3. University of Washington
  4. University of California, San Diego
  5. University of California, San Francisco
  6. Columbia University in the City of New York
  7. Stanford University
  8. University Pittsburgh
  9. University Pennsylvania
  10. Duke University

Patent Applications by Scientific Domain.

This section contains the number of patents organiized by high level scientific and technical domain. The data is arranged by the first Cooperative Patent Classification System (CPC) patent symbol assigned to the patent. This indicates the scope and nature of the patented invention for a patent or a patent application.

Global patent offices use patent classification as their lingua franca — the common language — for exchanging information about inventions and what scientific and technical art a patent contains. The classifications assigned to a patent are used by patent examiners to find prior art and to determine if a particular patent's claims are novel. Patent classifications are also used for global enforcement of patent rights, treaties, and agreements.

Class Class Definition First
(Original)
Inventive
(CrossRef)
CPC A61 Medical or Veterinary Science; Hygiene 33 188
CPC C12 Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or Genetic Engineering 20 121
CPC C07 Organic Chemistry 20 68
CPC H01 Basic Electric Elements 13 61
CPC G01 Measuring; Testing 20 36
CPC G06 Computing; Calculating; Counting 6 20
CPC H04 Electric Communication Technique 3 20
CPC B01 Physical or Chemical Processes or Apparatus in General 2 18
CPC F17 Storing or Distributing Gases or Liquids 1 19
CPC C08 Organic Macromolecular Compounds; Their Preparation or Chemical Working-up; Compositions Based Thereon 5 14
CPC B64 Aircraft; Aviation; Cosmonautics 3 7
CPC B32 Layered Products 0 10
CPC C10 Petroleum, Gas or Coke Industries; Technical Gases Containing Carbon Monoxide; Fuels; Lubricants; Peat 1 8
CPC G02 Optics 1 8
CPC C09 Dyes; Paints; Polishes; Natural Resins; Adhesives; Compositions Not Otherwise Provided For; Applications of Materials Not Otherwise Provided for 1 7
CPC F28 Heat Exchange in General 3 4
CPC C04 Cements; Concrete; Artificial Stone; Ceramics; Refractories 2 5
CPC A01 Agriculture; Forestry; Animal Husbandry; Hunting; Trapping; Fishing 2 4
CPC F27 Furnaces; Kilns; Ovens; Retorts 1 5
CPC G16 Information and Communication Technology [ICT] Specially Adapted for Specific Application Fields 1 5
CPC G21 Nuclear Physics; Nuclear Engineering 2 3
CPC B25 Hand Tools; Portable Power-driven Tools; Manipulators 1 4
CPC C01 Inorganic Chemistry 1 4
CPC F04 Positive - Displacement Machines for Liquids; Pumps for Liquids or Elastic Fluids 1 4
CPC H02 Generation; Conversion or Distribution of Electric Power 1 4
CPC B60 Vehicles in General 2 2
CPC C02 Treatment of Water, Waste Water, Sewage, or Sludge 1 3
CPC F01 Machines or Engines in General; Engine Plants in General; Steam Engines 1 2
CPC G08 Signalling 1 1
CPC Y02 Technologies or Applications for Mitigation or Adaptation Against Climate Change 0 2
CPC G10 Musical Instruments; Acoustics 1 0

Up to Start Of Table

Count of Inventors by Country and U.S. State

Patent Applications by country and state based on location information of first named inventors and all listed inventors.

Country First Named Inventors All Inventors
United States of America 149 488
China PRC 1 3
Italy 0 3
Canada 0 1
United Kingdom 0 1
Singapore 0 1
U.S. State First Named Inventors All Inventors
California 25 93
Massachusetts 14 43
Pennsylvania 10 26
Ohio 9 24
Colorado 8 31
Maryland 8 30
Texas 7 23
Illinois 6 28
Florida 6 21
New York 5 22
Arizona 5 14
Connecticut 4 13
Virginia 4 12
Iowa 3 12
New Jersey 3 12
Tennessee 3 9
Washington 2 6
Kentucky 2 5
Michigan 2 5
North Carolina 2 5
Utah 2 5
Idaho 2 4
Indiana 2 4
Louisiana 2 4
Nevada 2 4
Oregon 2 4
Missouri 2 3
Kansas 1 5
New Mexico 1 4
Georgia 1 3
Rhode Island 1 2
Wisconsin 1 2
West Virginia 1 2
District of Columbia 1 1
South Carolina 0 4
Alabama 0 1
Mississippi 0 1

Up to Start Of Table

Count of Assignees and Applicants by Country and U.S. State

Patent Applications by country and state based on location information of Assignees and Applicants.

Country Assignees Applicants
United States of America 50172
Italy 01
Netherlands 01
United Kingdom 01
U.S. State Assignees Applicants
California 1128
Massachusetts 917
Texas 37
Maryland 211
Ohio 210
Florida 28
District of Columbia 27
Virginia 24
Iowa 23
New Jersey 23
Missouri 22
Washington 22
Pennsylvania 110
Illinois 18
New York 16
Kentucky 12
Michigan 12
North Carolina 12
Louisiana 11
New Mexico 11
Oregon 11
Arizona 08
Colorado 07
Idaho 04
Connecticut 03
Utah 03
Indiana 02
Nevada 02
Tennessee 02
West Virginia 02
Georgia 01
Kansas 01
South Carolina 01
Wisconsin 01

Up to Start Of Table

Technology Center Explainer

How Tech Centers and Art Units Are Organized And Why It Matters

Patents travel from Technology Center to Art Unit to Group Art Unit to Patent Examiner.

The USPTO's patent corps is organized into Technology Centers (TCs), groups of patent examiners with specific scientific and technical domain expertise. Technology Centers are further divided into Art Units (AUs) organized by major types of inventive art within a scientific or technical domain. Art Units are organized into Group Art Units, even more specialized and granular teams of examiners.

Group Art Units (GAUs) are where patent examiners prosecute patent applications. Patent applications are docketed to examiners based on of specific subject matter classifications of a particular GAU.

Understanding Technology Centers, Art Units and Group Art Units helps you understand what type of inventions are being prosecuted within each scientific and technical domain, how long it takes from the date a patent application is filed to the time a final decision on the patentability of the invention is made.

Patents examined here cover:

Art Unit Technical & Scientific Domains
1610 Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
1620 Organic Chemistry
1630 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
1640 Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
1650 Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzyme
1660 Plants

About Plant Patents

Plant Patents are granted by the Government to an inventor who has invented or discovered and asexually reproduced a distinct and new variety of plant, other than a tuber propagated plant or a plant found in an uncultivated state. If you've ever eaten a pluot, you've enjoyed the fruit of a plant patent.

Plant patent numbers begin with a "PP" followed by a five digit number. The first Plant Patent was issued in 1931. Plant patents are valid for 20 years from the filing date.

Patents examined here cover:

Art Unit Technical & Scientific Domains
1710 Coating, Etching, Cleaning, Single Crystal Growth
1720 Fuel Cells, Batteries, Solar Cells, Liquid Crystal Composition
1730 Metallurgy, Metal Working, Inorganic Chemistry, Catalysts, Electrophotography, Photolithography
1740 Tires, Adhesive Bonding, Glass/Paper making, Plastics Shaping & Molding
1760 Organic Chemistry, Polymers, Compositions
1770 Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
1780 Miscellaneous Articles, Stock Material, Adhesive Composition, Fabrics
1790 Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry

Patents examined here cover:

Art Unit Technical & Scientific Domains
2110 Coating, Etching, Cleaning, Single Crystal Growth
2120 Miscellaneous Articles, Stock Material, Adhesive Composition, Fabrics
2130 Fuel Cells, Batteries, Solar Cells, Liquid Crystal Composition
2140/2170 Metallurgy, Metal Working, Inorganic Chemistry, Catalysts, Electrophotography, Photolithography
2150/2160 Tires, Adhesive Bonding, Glass/Paper making, Plastics Shaping & Molding
2180 Organic Chemistry, Polymers, Compositions
2190 Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus

Patents examined here cover:

Art Unit Technical & Scientific Domains
2410/2460/2470 Multiplex, VoIP
2420 Cable and Television
2430/2490 Cryptography and Security
2440/2450 Computer Networks
2480 Recording and Compression

Patents examined here cover:

Art Unit Technical & Scientific Domains
2610 Computer Graphic Processing, 3D Animation, Display Color Attribute, Object Processing, Hardware and Memory
2620 Selective Visual Display Systems
2630 Digital and Optical Communications
2640 Telecommunications: Analog Radio Telephone; Satellite and Power Control; Transceivers, Measuring and Testing; Bluetooth; Receivers and Transmitters; Equipment Details
2650 Videophones and Telephonic Communications; Audio Signals; Digital Audio Data Processing; Linguistics, Speech Processing and Audio Compression
2660 Digital Cameras; Image Analysis; Applications; pattern Recognition; Color and Compression; Enhancement and Transformation
2670 Facsimile; Printer; Color; halftone; Scanner; Computer Graphic Processing; 3-D Animation; Display Color; Attributes; Object Processing; Hardware and Memory
2680 Telemetry and Code Generation; Vehicles and System Alarms; Selective Communication; Dynamic Storage Systems; Mechanical parts of Disk Drives; Signal Processing and Control Processing in Disk Drives
2690 Selective Visual Display Systems

More broadly TC 2800 Art Units cover Semiconductors/Memory, Circuits/Measuring and Testing, Optics/Photocopying, Printing/Measuring and Testing.

Patents examined here cover:

Art Unit Technical & Scientific Domains
2810/2820/2890 Semiconductors/Memory
2830/2840 Electrical Circuits and Systems
2850/2860 Printing/Measuring and Testing
2870/2880 Optics

About Design Patents

The design FOR an article. Not to the design OF an article.

Patents examined here cover Design patents cover the appearance of an article. The design for an article consists of the visual characteristics embodied in or applied to an article. Since a design is manifested in appearance, the subject matter of a design patent application may relate to the configuration or shape of an article, to the surface ornamentation applied to an article, to the combination of configuration and surface ornamentation.

Design is inseparable from the article to which it is applied and cannot exist alone merely as a scheme of surface ornamentation. It must be a definite, preconceived thing, capable of reproduction and not merely the chance result of a method.

Design patent numbers begin with a "D" followed by a six-digit number. The first Design Patent was issued in 1843. The term of a design patent is 15 years measured from the date of grant if the design application was filed on or after May 13, 2015 (or 14 years if filed before May 13, 2015).

Patents examined here cover:

Art Unit Technical & Scientific Domains
3610 Surface Transportation
3620 Business Methods — Incentive Programs, Coupons; Operations Research; Electronic Shopping; Health Care; Point of Sale, Inventory, Accounting; Cost/Price, Reservations, Shipping and Transportation; Business Processing
3630 Static Structures, Supports and Furniture
3640 Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
3650 Material and Article Handling
3660 Computerized Vehicle Controls and Navigation, Radio Wave, Optical and Acoustic Wave Communication, Robotics, and Nuclear Systems
3670 Wells, Earth Boring/Moving/Working, Excavating, Mining, Harvesters, Bridges, Roads, Petroleum, Closures, Connections, and Hardware
3680 Business Methods — Incentive Programs, Coupons; Electronic Shopping; Business Cryptography, Voting; Health Care; Point of Sale, Inventory, Accounting; Business Processing, Electronic Negotiation
3690 Business Methods — Finance/Banking/ Insurance

Patents examined here cover:

Art Unit Technical & Scientific Domains
3710 Amusement and Education Devices
3720 Manufacturing Devices and Processes, Machine Tools and Hand Tools
3730 Sheet Container Making, Package Making, Receptacles, Shoes, Apparel, and Tool Driving or Impacting
3740 Thermal and Combustion Technology, Motive and Fluid Power Systems
3750 Fluid Handling and Dispensing
3760 Refrigeration, Vaporization, Ventilation, and Combustion
3770 Medical & Surgical Instruments, Treatment Devices, Surgery and Surgical Supplies
3780 Body Treatment, Kinestherapy, and Exercising

FedInvent Patents

Each week FedInvent analyzes newly granted patents and published patent applications whose origins lead back to funding from the US federal government. We assemble a weekly patent catalog and analyze the inventions, the inventors, and the entities who received the patents. We map the patents back to the agency that funded the R&D that led to the new invention. FedInvent uses the funding opportunity descriptions, the grants, and the contracts that define the research areas of interest ,and the R&D policies and priorities of that drove and are driving the funding to organize each week's patents.

ABOUT OUR DATA

The weekly patent catalog includes patents with government interest statements indicating federal funding; and patents where the assignee, the owner of the invention, is the federal government. This includes work on federal grants, work on federal contracts, innovation by Federal Research and Development Centers (FFRDCs) funded by Federal Departments, and University Affiliated Research Centers funded by DoD.

Not every inventor is a government contractor. There are many inventions conceived and patented by scientists and engineers working for the federal government or serving in the military.

THE NUMBERS MAY NOT MATCH THE NUMBER OF PATENTS WE ANALYZE EACH WEEK

The numbers in the tables presented on this page will not add up to the number of patents granted each week because patents are counted by each agency that funded the creation of the invention. Patents and funding have a many-to-many relationship. One patent may have more than one funding grant or contract associated with it. A grant or contract may lead to more than one patent. More than one agency may have funded the inventors or the contract. More than one university or business may have worked together on an invention. When we report the numbers here, we associate a patent with all of the entities and funding that are reflected on the patent and report them to you. This approach presents a more complete picture of what's going on in the federal innovation ecosphere. Put another way, the numbers in the tables presented on this page may not always add up to the number of patents each week because patents are counted by each agency that funded the creation of the invention.

Subscribe to The FedInvent™ Newsletter

 The latest from FedInvent delivered right to your inbox.